
Ozempic maker Novo Nordisk breach exposed patients’ clinical trial data
Novo Nordisk said this security incident affected patient data, including health information and birth year

Ozempic maker Novo Nordisk breach exposed patients’ clinical trial data
Novo Nordisk said this security incident affected patient data, including health information and birth year

The U.S. restricted Anthropic’s powerful Fable model. Cybersecurity experts say that could backfire
Fable 5 was built to help with advanced cybersecurity work. Its sudden shutdown highlights a dilemma at the heart of AI security: the same tools can aid both defenders and attackers


Trump’s Genesis Mission puts AI to work on nuclear weapons
The Department of Energy bills Genesis as an AI push for scientific discovery. Its first public challenges tell a different story

Timnit Gebru
On safeguarding independent research in the age of big tech

Jieneng Chen
Creating artificial-intelligence tools for cancer detection

The lab never sleeps. Can the science keep up?
Robots and AI are running experiments around the clock, from battery chemistry to cancer therapies. But can they be trusted to get it right?

How we chose the 2026 Young American Scientists
Scientific American used expert recommendations and data analysis to identify 28 exceptional early-career researchers

Kaiyi Jiang
Creating AI platforms to discover new therapeutics

Mikhail Kolmogorov
Developing software to reveal large genetic changes that lead to cancer

Tixiao Shan
Teaching robots how to recognize and interpret their surroundings

Alex L. Zhang
Making artificial-intelligence recursive language models more efficient

James Manyika
The Google senior vice president talks about the need to reset the relationship between the government and academic and industrial science